Literature DB >> 27028619

Gastrointestinal Microbiota and Colon Cancer.

Georgina L Hold1.   

Abstract

The human gut microbiota plays a major role in the development and maintenance of good health. Many recent studies have attempted to define links between microbiota residents, their function and the development of colorectal cancer (CRC). Gut microbiota drive the development of inflammation within the colon and such inflammation is implicated in colonic neoplastic development. Although the precise mechanisms through which the microbiota is involved in cancer development remain elusive, the message is clear: the microbiota contributes to cancer risk by influencing a number of key host processes. It is also recognized that we have the ability to influence the role of the gut microbiota by considering our nutritional intake. We have always known that 'we are what we eat' but it is also true that 'they (our gut microbiota) are what we eat'. We therefore have a huge opportunity to positively influence our health through microbial manipulation. There is now a clear need to move past defining the constituents of the gastrointestinal microbiota and to focus more on understanding the functional capabilities of the resident microbial community and how this impacts on host health. One such emerging concept is the development of microbial biofilms which can form in the gut in conjunction with CRC tissue. By better understanding of the interaction between the host and its resident microbiota, in the context of health and cancer development, we will open new therapeutic and diagnostic opportunities for reducing the CRC global health burden.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27028619     DOI: 10.1159/000443358

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  22 in total

Review 1.  MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.

Authors:  Xiang Li; Jing Nie; Qian Mei; Wei-Dong Han
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

Review 2.  Nutraceuticals in colorectal cancer: A mechanistic approach.

Authors:  Marco Rossi; S E Y E D Sina Mirbagheri; Ali Keshavarzian; Faraz Bishehsari
Journal:  Eur J Pharmacol       Date:  2018-06-20       Impact factor: 4.432

3.  A Multi-Omics Study of Familial Lung Cancer: Microbiome and Host Gene Expression Patterns.

Authors:  Ying Chen; Yunchao Huang; Xiaojie Ding; Zhenlin Yang; Liang He; Mingjie Ning; Zhenghong Yang; Daqian He; Lijuan Yang; Zhangyi Liu; Yan Chen; Guangjian Li
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

4.  Extending colonic mucosal microbiome analysis-assessment of colonic lavage as a proxy for endoscopic colonic biopsies.

Authors:  Euan Watt; Matthew R Gemmell; Susan Berry; Mark Glaire; Freda Farquharson; Petra Louis; Graeme I Murray; Emad El-Omar; Georgina L Hold
Journal:  Microbiome       Date:  2016-11-25       Impact factor: 14.650

5.  Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles.

Authors:  Christine M Bassis; Nicholas M Moore; Karen Lolans; Anna M Seekatz; Robert A Weinstein; Vincent B Young; Mary K Hayden
Journal:  BMC Microbiol       Date:  2017-03-31       Impact factor: 3.605

Review 6.  Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.

Authors:  Jing Gao; Kang Xu; Hongnan Liu; Gang Liu; Miaomiao Bai; Can Peng; Tiejun Li; Yulong Yin
Journal:  Front Cell Infect Microbiol       Date:  2018-02-06       Impact factor: 5.293

Review 7.  Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?

Authors:  Nuttavut Sumransub; Kornpong Vantanasiri; Ajay Prakash; Emil Lou
Journal:  Mol Ther Oncolytics       Date:  2021-05-14       Impact factor: 7.200

8.  Japanese traditional dietary fungus koji Aspergillus oryzae functions as a prebiotic for Blautia coccoides through glycosylceramide: Japanese dietary fungus koji is a new prebiotic.

Authors:  Hiroshi Hamajima; Haruka Matsunaga; Ayami Fujikawa; Tomoya Sato; Susumu Mitsutake; Teruyoshi Yanagita; Koji Nagao; Jiro Nakayama; Hiroshi Kitagaki
Journal:  Springerplus       Date:  2016-08-11

Review 9.  Microbiota and neurologic diseases: potential effects of probiotics.

Authors:  Giulia Umbrello; Susanna Esposito
Journal:  J Transl Med       Date:  2016-10-19       Impact factor: 5.531

Review 10.  Gut microbiome modulates efficacy of immune checkpoint inhibitors.

Authors:  Ming Yi; Shengnan Yu; Shuang Qin; Qian Liu; Hanxiao Xu; Weiheng Zhao; Qian Chu; Kongming Wu
Journal:  J Hematol Oncol       Date:  2018-03-27       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.